Top-level M&A activity and consequent restructuring of the industry was the talk of 2009. It embroiled all three leading animal health companies and several further down the list. The ripples of these actions are being felt deep into 2010. IBI principal analyst Ashley Yeo describes how the ...
Please Login to read the full article.
